πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β€” grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≀24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β€” use filters for patent-cliff planning.

Page 12 of 14

  1. US 7399862

    5-HT4 receptor agonist compounds

    Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7396933

    Quinolinone-carboxamide compounds

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7375114

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7375181

    Process for purifying glycopeptide phosphonate derivatives

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7368463

    Substituted 4-amino-1-benzylpiperidine compounds

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7358244

    Azabicycloalkane compounds

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7355046

    Biphenyl derivatives

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7351717

    Substituted pyrrolidine and related compounds

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7351718

    Substituted pyrrolidine and related compounds

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7351704

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7351791

    Intermediate for preparing glycopeptide derivatives

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7351691

    Glycopeptide phosphonate derivatives

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7345175

    Biphenyl derivatives

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7345060

    Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7341993

    Cross-linked glycopeptideβ€”cephalosporin antibiotics

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7332471

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7329752

    Carbamate compounds as 5-HT4 receptor agonists

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7320990

    Crystalline form of a biphenyl compound

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7317102

    Diarylmethyl and related compounds

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7317023

    Diaryl ether Ξ²2 adrenergic receptor agonists

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7317022

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7301004

    Process for preparing glycopeptide phosphonate derivatives

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7288657

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7285564

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7279458

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7265133

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7265086

    Glycopeptide carboxy-saccharide derivatives

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7262205

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7256294

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7250414

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7244705

    Polyacid glycopeptide derivatives

    Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7238709

    Therapeutic carbamates

    Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7226946

    Substituted phenol compounds useful for anesthesia and sedation

    Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7226950

    Sodium channel modulators

    Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7223783

    Indolinone derivatives

    Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7217738

    Ξ²2-adrenergic receptor agonists

    Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7208471

    Glycopeptide phosphonate derivatives

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7208515

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7195876

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7183292

    Substituted pyrrolidine and related compounds

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7183323

    Sodium channel modulators

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7179794

    Multivalent macrolide antibiotics

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7173039

    Protein kinase inhibitors

    Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7160984

    Process for preparing glycopeptide derivatives

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7157554

    Glycopeptide carboxy-saccharide derivatives

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7151115

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7141671

    Biphenyl derivatives

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7132422

    Sodium channel modulators

    Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.